Providing support for medicine development by academics and clinical researchers is a priority for the European Medicines Agency. The recent launch of free scientific advice to academia and non-profit research organizations developing orphan medicines can help align research with regulatory requirements early during medicine development and enhance the chances of success.
- Rosa Gonzalez-Quevedo
- Constantinos Ziogas
- Anthony Humphreys